DCX Systems Ltd

Purchase orders in normal course

• DCX Systems received purchase orders totaling INR 15.19 crore in normal course for cable and wire harness assemblies.
• Orders are domestic and export.
• Raneal Advanced Systems Pvt. Ltd. received export orders for PCB assemblies worth INR 3.09 crore.

Event

• Investor presentation for Q1 FY2026-27 unaudited results uploaded for quarter ended June 30, 2026; link on company site.

Subject

• Press release issued for un-audited Q1 FY27 results for quarter ended June 30, 2026.

Release availability

• Full release available on the company website, with the link provided.

Date and contact

• Dated August 12, 2026; Company Secretary is Gurumurthy Hegde.

Fund utilisation status

• Fundraising mode: IPO and QIP.
• Net proceeds available for utilisation disclosed for IPO and QIP.
• Deviation/variation in fund use: No deviation for IPO or QIP.
• Audit Committee comments: No comments; Monitoring agency: CARE Ratings Limited.
• Utilisation status: Funds partially utilised under both IPO and QIP.

Issue Overview

• IPO: Fresh issue of equity shares; proceeds for debt repayment, capex, working capital, and GCP.
• QIP: Public issue of equity shares; proceeds for JV/subsidiaries and general corporate purposes.
• Revision/approval: Allocation within the offer document revised with shareholder approval; no undersubscription.
• Objectives: Debt repayment, capex, working capital, acquisitions, general corporate purposes.
• Risks: PAT loss; Israeli Niart subsidiary incurring product development costs.

Utilisation of Proceeds

• IPO utilisation not fully as disclosed; RASPL investment revised to loan repayment; GCP delayed.
• Shareholder approval obtained for reallocations; postal ballot dated May 6, 2024.
• Borrowings: Fully utilised.
• Working capital: Fully utilised.
• RASPL: Revised to 19.80 crore; utilised.
• GCP: End-quarter utilisation 67.23; unutilised 16.00.
• Unutilised IPO funds: 16.00 parked in fixed deposits (Axis Bank).
• GCP extension: Board resolution Feb 12, 2026; extension to FY29.
• QIP: Utilisation not per disclosures; unutilised funds remained; three-tranche payments planned.
• NIART: 209.00 utilised; no unutilised.
• JV: 0 utilised; 200.00 unutilised; payments to be in three tranches.
• GCP (QIP): 0.72 utilised; 276.93 unutilised; funds parked in fixed deposits.
• ELTX infusion: Rs 84 crore infused into ELTX as per BSE announcement.
• JVC/Make in India: Approvals in progress; investment expected FY29.

Governance and Compliance

• Approvals: IPO - shareholder approval obtained; GCP extension approved via board resolution.
• QIP: Government/statutory approvals for ELTX in progress; JV formation under Make in India underway.
• Material events: PAT loss; Niart Systems Israel developing; potential credit impact.
• Other information: Rs 84 crore infusion into ELTX noted; investment timing may affect benefits.
• Disclosures: No material deviations from prior MA reports; ongoing approvals noted.

General Corporate Purpose (GCP)

• GCP (IPO): 21.50 crore utilised; salaries, transport, materials; board approved extension to FY29 for remaining.
• GCP: Unutilised IPO GCP 16.00 crore parked in fixed deposits.
• GCP revisions: GCP allocations revised to ~83.23 crore; RASPL reallocation to working capital impact.
• GCP (QIP): 0.72 crore utilised; 276.93 crore unutilised; funds parked in fixed deposits.
• Overall: Unutilised GCP to be deployed for working capital or capex as per board approvals.

Financial results approved

• Un-Audited standalone results for quarter ended 30 June 2026 approved.
• Un-Audited consolidated results for quarter ended 30 June 2026 approved.
• Limited Review Report by Statutory Auditors included.

AGM and voting provisions

• 15th AGM to be held on 28 September 2026 via VC/OAVM.
• Cut-off date for voting fixed at 18 September 2026.
• AGM notice to shareholders and exchanges to be issued.

Cost auditor appointment

• Approved appointment of M Ashok Kumar as Cost Auditor for FY 2026-27.

Audit/regulatory actions

• Audit Committee reviewed and Board approved results.
• Statutory auditors conducted limited review of the quarter ended 30 June 2026.

Meeting Details

• Date: August 12, 2026; time and location not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for quarter ended June 30, 2026.

Other Notes

• No additional material governance or financial actions disclosed.

Website and IR page revision

• The official website and Investor Relations page have been redesigned for improved UI and navigation.
• Mandatory disclosures under Regulation 46(2) SEBI LODR are hosted in the new IR section.
• Link to the updated site is www.dcxindia.com for all stakeholders.

ELTX Systems Private Limited – deal overview

• Target: ELTX Systems Private Limited, associate and joint venture with ELTA Systems (Israel).
• Industry: Defence and Aerospace.
• Paid-up capital ₹2.5 million; turnover Nil; loss after tax ₹1.30 million; net worth ₹1.19 million.
• Related party: ELTX is an associate and joint venture; promoter group has no interest.
• Rationale: rights issue to support ELTX growth using QIP proceeds.
• Regulatory approvals: Not Applicable.
• Timeline: Equity shares allotted on 14 July 2026.
• Consideration: cash; 2,34,229 shares at premium ₹3,590 totaling ₹84.32 crore.
• Holding after acquisition: 37% stake remains.
• Background: design and manufacture of integrated electronic systems; incorporated 10 Oct 2025; India.